| 0.9227 -0.027 (-2.8%) | 01-29 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.3  |
1-year : | 1.53 |
| Resists | First : | 1.11 |
Second : | 1.3 |
| Pivot price | 1.03 |
|||
| Supports | First : | 0.81 | Second : | 0.67 |
| MAs | MA(5) : | 0.98 |
MA(20) : | 1.02 |
| MA(100) : | 1.87 |
MA(250) : | 2.93 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2  |
| %K %D | K(14,3) : | 14.8 |
D(3) : | 24.8 |
| RSI | RSI(14): 31.5 |
|||
| 52-week | High : | 17.2 | Low : | 0.81 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AIFF ] has closed below the lower bollinger band by 1.4%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ AIFF ] is to continue within current trading range. It is unclear right now based on current values. 61.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.98 - 0.99 | 0.99 - 0.99 |
| Low: | 0.87 - 0.88 | 0.88 - 0.88 |
| Close: | 0.91 - 0.93 | 0.93 - 0.94 |
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Mon, 22 Dec 2025
Can Firefly Neuroscience Stock Recover If Markets Fall? - Trefis
Fri, 31 Oct 2025
Firefly Neuroscience Approves Increase in Authorized Shares - TipRanks
Wed, 22 Oct 2025
Windsor Private Capital sells Firefly Neuroscience (AIFF) shares for $290k - Investing.com
Tue, 14 Oct 2025
Windsor private capital sells Firefly Neurosciences (AIFF) shares for $456k - Investing.com
Thu, 09 Oct 2025
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Firefly Neuroscience, Inc. (NASDAQ: AIFF) - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 0 (M) |
| Shares Float | 13 (M) |
| Held by Insiders | 1.176e+007 (%) |
| Held by Institutions | 28.1 (%) |
| Shares Short | 479 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -8.65e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -632.5 % |
| Return on Assets (ttm) | -61.5 % |
| Return on Equity (ttm) | -340.9 % |
| Qtrly Rev. Growth | 1 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -2.3 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 500170 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|